Drug Search Results
More Filters [+]

Guanabenz

Alternative Names: guanabenz, wytensin
Latest Update: 2024-10-29
Latest Update Note: Clinical Trial Update

Product Description

Guanabenz belongs to the general class of medicines called antihypertensives. It is used to treat high blood pressure (hypertension). (Sourced from: https://www.mayoclinic.org/drugs-supplements/guanabenz-oral-route/description/drg-20064106)

Mechanisms of Action: ADRA2A Agonist,ADRA2B Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Germany | New Zealand | Peru | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Guanabenz

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Amyotrophic Lateral Sclerosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PROMISE

P2

Active, not recruiting

Amyotrophic Lateral Sclerosis

2018-10-28

Recent News Events